Charlotte's Web (CWBHF) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Jun, 2026Mission and legacy
Founded as a mission-driven organization, not a traditional company, and pioneered the CBD category.
Inspired by Charlotte Figi’s story, the brand became a leader in hemp-based CBD wellness and influenced global perceptions and laws.
Continues to honor its legacy through product innovation and partnerships.
Market leadership and brand strength
Holds the #1 market share in U.S. CBD, leading both eCommerce and retail channels.
Recognized for exceptional customer satisfaction with a Net Promoter Score of 92.2%.
Extensive media coverage and award-winning storytelling have built global brand recognition.
Product portfolio and innovation
Offers a broad portfolio: CBD, CBG, CBN, and low-dose THC products, plus functional mushroom blends.
New product launches in 2025 include fast-acting gummies for focus, sleep, and recovery.
Medical line addresses sleep, pain, anxiety, and overall wellness with advanced formulations.
Latest events from Charlotte's Web
- Q2 2026 saw revenue drop, margin expand, and a major equity conversion strengthen the balance sheet.CWBHF
Q2 2026 - All resolutions passed, with BAT gaining 40% ownership and a Medicare pilot seen as a major growth driver.CWBHF
AGM 2026 - Q1 2026 revenue dropped 9% and net loss widened, with a major BAT debt deal pending approval.CWBHF
Q1 2026 - Returned to growth as the #1 CBD brand, leveraging innovation, partnerships, and regulatory momentum.CWBHF
Investor presentation - Shareholders to vote on BAT transaction, director elections, and key governance matters.CWBHF
Proxy filing - Key votes include director elections and a debenture amendment that may shift company control.CWBHF
Proxy filing - Shareholders to vote on BAT's conversion to a control person, reshaping ownership and governance.CWBHF
Proxy filing - Transformed balance sheet, renewed growth, and Medicare pilot position drive future upside.CWBHF
Q4 2025 - Sequential revenue growth and cost cuts signal a turnaround amid regulatory challenges.CWBHF
Q2 2024